Home › Alzheimer's Disease › District of Columbia
Alzheimer's Disease clinical trials in District of Columbia
5 studies for Alzheimer's Disease are looking for participants at sites in District of Columbia.
Cities in District of Columbia
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- Georgetown University, Washington D.C.
RecruitingPhase 2
Ages 55 to 90 · All sexes · Updated Sep 1, 2026 · NCT06808984A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Georgetown University Medical Center, Washington D.C.
RecruitingPhase 3
Ages 60 to 85 · All sexes · Updated Aug 20, 2026 · NCT06976216Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- MedStar Washington Hospital Center - MedStar Heart and Vascular Institute, Washington D.C.
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 4, 2026 · NCT06563895Late Onset Alzheimer's Disease
- University of Washington, Washington D.C.
RecruitingObservational studyHealthy volunteers welcome
Ages 55 and older · All sexes · Updated May 18, 2026 · NCT05010603DC Longitudinal Study on Aging and Specimen Bank
- Georgetown University Memory Disorders Program, Washington D.C.
RecruitingObservational studyHealthy volunteers welcome
Ages 45 and older · All sexes · Updated Oct 24, 2019 · NCT03702907From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.